BHF vs FBP

The Advanced Deterministic Scorecard reveals significant concerns, with a weak Piotroski F-Score of 3/9 indicating poor financial health, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a low P/E of 4.52 and a Price/Book of 0.58 suggesting potential value, the company faces declining revenue (YoY -10.10%) and erratic earnings performance, including large negative surprises. Strong operating margins and ROE of 16.18% are offset by high debt/equity of 1.47 and extremely weak technical and dividend signals. Analysts consensus is a hold, but the stock trades above the conservative Graham Number of $188.54, raising valuation concerns.

FBP presents a stark contrast between strong profitability and deteriorating operational health, highlighted by a weak Piotroski F-Score of 2/9. While the company maintains a robust ROE of 19.04% and a consistent track record of earnings beats, the low health score and bearish insider sentiment suggest underlying systemic risks. The stock is currently trading slightly below its Graham Number ($24.73), suggesting a defensive value floor, though it remains far below its growth-based intrinsic value of $63.42. Overall, the strong earnings momentum is offset by poor deterministic health metrics and negative insider signals.